Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
7
×
boston top stories
life sciences
national blog main
clinical trials
boston
fda
investing
national top stories
deals
medical device
san francisco blog main
san francisco top stories
biotech ipos
cancer immunotherapy
chronic kidney disease
ipo
national
new york blog main
new york top stories
san diego blog main
san diego top stories
startups
ulcerative colitis
venture capital
20/20 healthcare partners
480 biomedical
acute myeloid leukemia
ally bridge group
alx oncology
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
arsenal medical
autoimmune diseases
berkeley lights
big data analytics
biofourmis
biovotion
What
raised
7
×
ipo
million
new
therapeutics
biotech
companies
company
develop
developing
diseases
drug
genetic
life
medicines
momentum
public
raises
science
treat
week
analysis
analytics
arrival
associated
bio
biofourmis
biotechs
bring
brings
club
continued
crop
data
days
debut
device
devices
dialysis
digital
Language
unset
Current search:
raised
×
biotech
×
" boston blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M